Alzheimer's disease

[video] Eli Lilly's Alzheimer Drug Fails Final-Stage Trial
Bloomberg
Wed, 11/23/16 - 10:27 am
Eli Lilly
Alzheimer's disease
clinical trials
solanezumab
Ex-Allergan prez Ingram forges $1B deal to sell Alzheimer’s biotech to Brent Saunders and the new crew at Allergan
Endpoints
Tue, 11/22/16 - 09:55 pm
Allergan
Brent Saunders
Doug Ingram
Alzheimer's disease
Chase Pharmaceuticals
$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market
Motley Fool
Mon, 11/21/16 - 02:35 pm
Alzheimer's disease
AstraZeneca
Biogen
Eli Lilly
Merck
Roche
BACE inhibitors
Solanezumab And The History Of The Future Of Treating Alzheimer's Disease
Forbes
Fri, 11/11/16 - 09:48 am
Alzheimer's disease
solanezumab
Eli Lilly
Merck can’t prove its Alzheimer’s drug works, yet, but it did just explain why it’s spending a fortune on PhIII
Endpoints
Thu, 11/3/16 - 09:49 am
Merck
Alzheimer's disease
verubecestat
clinical trials
A Little Known Drug Company Could Have The Answer For Some Alzheimer's Patients
Forbes
Fri, 10/7/16 - 09:04 am
Alzheimer's disease
Alzheon
ALK-801
Comorbidity Could Be Key To Alzheimer’s Clinical Trial Failures
Xtalks
Tue, 10/4/16 - 10:27 am
Alzheimer's disease
comorbidity
clinical trials
In One Expert's View, Eli Lilly's Alzheimer Drug Trial Has A Greater Than 60% Chance Of Success
Yahoo/Benzinga
Mon, 10/3/16 - 09:45 pm
Eli Lilly
Alzheimer's disease
solanezumab
Eli Lilly: This is Gonna Be Good
Barron's
Tue, 09/27/16 - 10:07 pm
Eli Lilly
solanezumab
Alzheimer's disease
Could This Alzheimer’s Disease Drug Really Be Worth $20 Billion?
Motley Fool
Mon, 09/19/16 - 03:41 pm
Biogen
Alzheimer's disease
aducanumab
Eisai launches research division in Massachusetts aimed at Alzheimer’s, I/O and autoimmune diseases
Endpoints
Thu, 09/15/16 - 09:29 am
Eisai
R&D
Massachusetts
Alzheimer's disease
autoimmune disease
Will MS Franchise & New Drugs Come To Biogen Rescue?
Bidness, ETC
Wed, 09/7/16 - 08:10 pm
Biogen
MS
multiple sclerosis
Nusinersen
SMA
aducanumab
Alzheimer's disease
Alzheimer’s player gets $47M, a new name and a pair of marquee board members
Endpoints
Wed, 09/7/16 - 09:40 am
Alzheimer's disease
Proclara Biosciences
NeuroPhage
Biogen Inc to Surge on FDA Win of Alzheimer’s Drug
Bidness, ETC
Fri, 09/2/16 - 09:49 am
Biogen
Alzheimer's disease
FDA
fast track
aducanumab
Biogen’s aducanumab data impress the media, but not the market
Fierce Biotech
Thu, 09/1/16 - 09:37 am
Biogen
aducanumab
Alzheimer's disease
Biogen touts a fresh set of early, upbeat results for Alzheimer’s drug
Endpoints
Wed, 08/31/16 - 08:53 pm
Biogen
Alzheimer's disease
aducanumab
Why Eli Lilly Execs Say Alzheimer's Drug Development Is Far From Dead
Forbes
Tue, 08/23/16 - 09:57 am
Eli Lilly
Alzheimer's disease
solanezumab
Lilly and AstraZeneca Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer's Disease
Yahoo
Mon, 08/22/16 - 11:36 am
Eli Lilly
AstraZeneca
AZD3293
fast track
FDA
Alzheimer's disease
Eisai joins hands with Biogen on PhIII Alzheimer’s BACE trial
Fierce Pharma
Wed, 08/10/16 - 10:11 am
Eisai
Biogen
BACE inhibitors
clinical trials
Alzheimer's disease
E2609
Biogen, Eisai’s Alzheimer’s Drug E2609 to Enter Late-Stage Trial
Bloomberg
Tue, 08/9/16 - 10:45 am
Biogen
Eisai
Alzheimer's disease
E2609

Pages